Celltheon has been developing Cell Engineering technologies since 2012. Celltheon has patents, granted and pending, for its CHOK-1 derived SUPERCELL™ cell line and its unique DNA and RNA vector elements that are applicable for recombinant biotherapeutics such as Mabs, Difficult to Express Proteins (DEP) as well as for CAR-T, Gene Therapy, and Cell Factories applications.

Biotechnology

Celltheon

Celltheon's headquarters in Union City, CA, United States

Amita Goel

Carlos Garcia

Anurag Goel

Nikhil Goel

Nicy Varghese

Divya Goel

Celltheon's Leadership Team includes Divya Goel and 1 others.

About

People

Amita Goel

Divya Goel